Your browser doesn't support javascript.
loading
Adenoma and colorectal cancer risks in Lynch syndrome, Lynch-like syndrome and familial colorectal cancer type X.
Bucksch, Karolin; Zachariae, Silke; Ahadova, Aysel; Aretz, Stefan; Büttner, Reinhard; Görgens, Heike; Holinski-Feder, Elke; Hüneburg, Robert; Kloor, Matthias; von Knebel Doeberitz, Magnus; Ladigan-Badura, Swetlana; Moeslein, Gabriela; Morak, Monika; Nattermann, Jacob; Nguyen, Huu Phuc; Perne, Claudia; Redler, Silke; Schmetz, Ariane; Steinke-Lange, Verena; Surowy, Harald; Vangala, Deepak B; Weitz, Jürgen; Loeffler, Markus; Engel, Christoph.
Afiliação
  • Bucksch K; Institute for Medical Informatics, Statistics and Epidemiology (IMISE), University of Leipzig, Leipzig, Germany.
  • Zachariae S; Institute for Medical Informatics, Statistics and Epidemiology (IMISE), University of Leipzig, Leipzig, Germany.
  • Ahadova A; Department of Applied Tumour Biology, Institute of Pathology, University Hospital Heidelberg, Heidelberg, Germany.
  • Aretz S; Cooperation Unit Applied Tumour Biology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Büttner R; Institute of Human Genetics, Medical Faculty, University of Bonn, Bonn, Germany.
  • Görgens H; National Center for Hereditary Tumor Syndromes, University Hospital Bonn, Bonn, Germany.
  • Holinski-Feder E; Institute of Pathology, University of Cologne, Cologne, Germany.
  • Hüneburg R; Department of Surgery, TU Dresden, Dresden, Germany.
  • Kloor M; Medizinische Klinik und Poliklinik IV, Campus Innenstadt, Klinikum der Universität München, Munich, Germany.
  • von Knebel Doeberitz M; MGZ-Medical Genetics Center, Munich, Germany.
  • Ladigan-Badura S; Department of Internal Medicine I, University Hospital Bonn, Bonn, Germany.
  • Moeslein G; National Center for Hereditary Tumour Syndromes, University Hospital Bonn, Bonn, Germany.
  • Morak M; Department of Applied Tumour Biology, Institute of Pathology, University Hospital Heidelberg, Heidelberg, Germany.
  • Nattermann J; Cooperation Unit Applied Tumour Biology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Nguyen HP; Department of Applied Tumour Biology, Institute of Pathology, University Hospital Heidelberg, Heidelberg, Germany.
  • Perne C; Cooperation Unit Applied Tumour Biology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Redler S; Department of Medicine, Knappschaftskrankenhaus, Ruhr-University Bochum, Bochum, Germany.
  • Schmetz A; Ev. Bethesda Krankenhaus Duisburg, Center for Hereditary Tumors, Duisburg, Germany.
  • Steinke-Lange V; Medizinische Klinik und Poliklinik IV, Campus Innenstadt, Klinikum der Universität München, Munich, Germany.
  • Surowy H; MGZ-Medical Genetics Center, Munich, Germany.
  • Vangala DB; Department of Internal Medicine I, University Hospital Bonn, Bonn, Germany.
  • Weitz J; Department of Human Genetics, Medical Faculty, Ruhr-University Bochum, Bochum, Germany.
  • Loeffler M; Institute of Human Genetics, Medical Faculty, University of Bonn, Bonn, Germany.
  • Engel C; National Center for Hereditary Tumor Syndromes, University Hospital Bonn, Bonn, Germany.
Int J Cancer ; 150(1): 56-66, 2022 01 01.
Article em En | MEDLINE | ID: mdl-34469588
ABSTRACT
Lynch syndrome (LS), Lynch-like syndrome (LLS) and familial colorectal cancer type X (FCCX) are different entities of familial cancer predisposition leading to an increased risk of colorectal cancer (CRC). The aim of this prospective study was to characterise and to compare the risks for adenoma and CRC in these three risk groups. Data was taken from the registry of the German Consortium for Familial Intestinal Cancer. Patients were prospectively followed up in an intensified colonoscopic surveillance programme that included annual examinations. Cumulative risks for adenoma and CRC were calculated separately for LS, LLS and FCCX, and then for males and females. Multivariate Cox regression was used to analyse the independent contributions of risk group, mismatch repair gene (within LS), sex and previous adenoma. The study population comprised 1448 individuals (103 FCCX, 481 LLS and 864 LS). The risks were similar for colorectal adenomas, but different for first and metachronous CRC between the three risk groups. CRC risk was highest in LS, followed by LLS and lowest in FCCX. Male sex and a prevalent adenoma in the index colonoscopy were associated with a higher risk for incident adenoma and CRC. In patients with LS, CRC risks were particularly higher in female MSH2 than MLH1 carriers. Our study may support the development of risk-adapted surveillance policies in LS, LLS and FCCX.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Colorretais / Neoplasias Colorretais Hereditárias sem Polipose / Biomarcadores Tumorais / Adenoma Tipo de estudo: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Colorretais / Neoplasias Colorretais Hereditárias sem Polipose / Biomarcadores Tumorais / Adenoma Tipo de estudo: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2022 Tipo de documento: Article